| 000 | 01744 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515002053.0 | ||
| 264 | 0 | _c20060112 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0007-0963 | ||
| 024 | 7 |
_a10.1111/j.1365-2133.2005.06805.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobak, E | |
| 245 | 0 | 0 |
_aRichter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cOct 2005 |
||
| 300 |
_a833-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xpathology |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xpathology |
| 650 | 0 | 4 |
_aNose Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSyndrome |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aGóra-Tybor, J | |
| 700 | 1 | _aKordek, R | |
| 700 | 1 | _aWawrzyniak, E | |
| 700 | 1 | _aBartkowiak, J | |
| 700 | 1 | _aBednarek, A | |
| 700 | 1 | _aConstantinou, M | |
| 700 | 1 | _aKałuzewski, B | |
| 700 | 1 | _aRobak, T | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 153 _gno. 4 _gp. 833-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2133.2005.06805.x _zAvailable from publisher's website |
| 999 |
_c15813211 _d15813211 |
||